Treating lung tumors with pulsed electric field before surgery
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new device that uses brief electrical pulses (pulsed electric field or PEF) to treat lung tumors before they are surgically removed. The goal is to see if this approach can be safely added to standard lung cancer surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a lung tumor between 1.5 cm and 4 cm that looks like it could be cancer.
- Your doctor has already decided that surgery to remove part of your lung is a good option for you.
- You are healthy enough to have general anesthesia and the study procedure.
- You are not currently receiving chemotherapy, radiation, or other cancer treatments for this tumor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat small lung cancers during a scope procedure, followed by surgery. The treatment uses freezing and heat to destroy the tumor, and the study checks how safe and effective it is.
This study tests a new system called EAS1 for people with early-stage lung cancer who are already scheduled for surgery. The goal is to see if the device is safe and works well, and it may offer a less invasive way to remove small lung tumors.
This study tests a new treatment that uses electric pulses to destroy early-stage lung tumors without surgery. It is for people who cannot have surgery or radiation, or who choose not to.
This trial tests whether combining pembrolizumab (an immune treatment) with a lung ablation procedure can be safer and more effective for advanced non-small cell lung cancer after standard first treatment fails or the cancer comes back. It may help shrink tumors and improve control of the disease.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
This trial tests a new way to treat breast cancer that has spread to the skin or just under the skin. It uses short electric pulses to target tumors without cutting. The goal is to see if this approach can safely destroy cancer cells in those spots.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.